METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo tackles tough head and neck cancers
Disease control OngoingThis study tests a combination of an immunotherapy drug (cemiplimab) and low-dose chemotherapy (paclitaxel and carboplatin) in 46 people with head and neck cancer that has returned or spread. The goal is to see if this mix can shrink tumors better than current treatments. Partici…
Matched conditions: METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated May 19, 2026 11:52 UTC
-
New combo shows promise for tough head and neck cancers
Disease control OngoingThis study tests whether adding the drug ipatasertib to standard immunotherapy (pembrolizumab) works better than immunotherapy alone for people with head and neck cancer that has come back or spread. About 52 adults with incurable, advanced cancer will take part. The goal is to s…
Matched conditions: METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Radiation boost may improve immunotherapy for advanced head and neck cancer
Disease control OngoingThis study compares two treatments for head and neck cancer that has spread to other parts of the body. All participants receive the immunotherapy drug pembrolizumab plus chemotherapy. Half also get targeted radiation to their tumors. The goal is to see if adding radiation helps …
Matched conditions: METASTATIC ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 14, 2026 12:02 UTC